Candidate gene analysis of SPARCL1 gene in patients with multiple sclerosis

Diego Scalabrini, Chiara Fenoglio, Elio Scarpini, Milena De Riz, Cristoforo Comi, Eliana Venturelli, Francesca Cortini, Mirko Piola, Chiara Villa, Paola Naldi, Francesco Monaco, Nereo Bresolin, Daniela Galimberti

Research output: Contribution to journalArticle

Abstract

Recently, proteomic analysis in cerebrospinal fluid (CSF) from patients with MS identified four proteins which are present in MS but not in normal human CSF, including SPARCL1, an extracellular matrix-associated protein member of the SPARC family. One hundred eighty-six patients with MS and 185 age-matched controls were genotyped for A/G single nucleotide polymorphism (SNP) in exon 1 (rs1049539), C/G SNP in exon 4 (rs1049544), resulting in a substitution of an aspartate with an histidine, and A/G substitution in the exon 5 (rs1130643), leading to the substitution of alanine with threonine. No significant differences in either allelic or genotypic frequency of the three SNPs were found (P > 0.05), even in stratifying MS patients according to the course of the disease. Stratifying according to gender, a trend towards a decreased frequency of the C/C genotype of the rs1049544 was observed in male patients as compared with male controls (30.2% versus 44.0%; P = 0.217). Despite proteomic studies in CSF from MS patients suggested an important role for SPARCL1 in the development of the disease, SPARCL1 gene does not appear to act as susceptibility factor for MS in the population investigated here. However, the frequency of the C/C genotype of rs1049544 was decreased in male patients, possibly conferring a lower risk of developing MS in male population. Further studies are needed to clarify this issue.

Original languageEnglish
Pages (from-to)173-176
Number of pages4
JournalNeuroscience Letters
Volume425
Issue number3
DOIs
Publication statusPublished - Oct 2 2007

Fingerprint

Genetic Association Studies
Multiple Sclerosis
Genes
Single Nucleotide Polymorphism
Cerebrospinal Fluid
Exons
Proteomics
Genotype
Extracellular Matrix Proteins
Threonine
Histidine
Aspartic Acid
Alanine
Population
Proteins

Keywords

  • Haplotype
  • Multiple sclerosis (MS)
  • Single nucleotide polymorphism (SNP)
  • SPARCL1

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Candidate gene analysis of SPARCL1 gene in patients with multiple sclerosis. / Scalabrini, Diego; Fenoglio, Chiara; Scarpini, Elio; De Riz, Milena; Comi, Cristoforo; Venturelli, Eliana; Cortini, Francesca; Piola, Mirko; Villa, Chiara; Naldi, Paola; Monaco, Francesco; Bresolin, Nereo; Galimberti, Daniela.

In: Neuroscience Letters, Vol. 425, No. 3, 02.10.2007, p. 173-176.

Research output: Contribution to journalArticle

Scalabrini, Diego ; Fenoglio, Chiara ; Scarpini, Elio ; De Riz, Milena ; Comi, Cristoforo ; Venturelli, Eliana ; Cortini, Francesca ; Piola, Mirko ; Villa, Chiara ; Naldi, Paola ; Monaco, Francesco ; Bresolin, Nereo ; Galimberti, Daniela. / Candidate gene analysis of SPARCL1 gene in patients with multiple sclerosis. In: Neuroscience Letters. 2007 ; Vol. 425, No. 3. pp. 173-176.
@article{139f1e7371f649e1931939e989b2d2b3,
title = "Candidate gene analysis of SPARCL1 gene in patients with multiple sclerosis",
abstract = "Recently, proteomic analysis in cerebrospinal fluid (CSF) from patients with MS identified four proteins which are present in MS but not in normal human CSF, including SPARCL1, an extracellular matrix-associated protein member of the SPARC family. One hundred eighty-six patients with MS and 185 age-matched controls were genotyped for A/G single nucleotide polymorphism (SNP) in exon 1 (rs1049539), C/G SNP in exon 4 (rs1049544), resulting in a substitution of an aspartate with an histidine, and A/G substitution in the exon 5 (rs1130643), leading to the substitution of alanine with threonine. No significant differences in either allelic or genotypic frequency of the three SNPs were found (P > 0.05), even in stratifying MS patients according to the course of the disease. Stratifying according to gender, a trend towards a decreased frequency of the C/C genotype of the rs1049544 was observed in male patients as compared with male controls (30.2{\%} versus 44.0{\%}; P = 0.217). Despite proteomic studies in CSF from MS patients suggested an important role for SPARCL1 in the development of the disease, SPARCL1 gene does not appear to act as susceptibility factor for MS in the population investigated here. However, the frequency of the C/C genotype of rs1049544 was decreased in male patients, possibly conferring a lower risk of developing MS in male population. Further studies are needed to clarify this issue.",
keywords = "Haplotype, Multiple sclerosis (MS), Single nucleotide polymorphism (SNP), SPARCL1",
author = "Diego Scalabrini and Chiara Fenoglio and Elio Scarpini and {De Riz}, Milena and Cristoforo Comi and Eliana Venturelli and Francesca Cortini and Mirko Piola and Chiara Villa and Paola Naldi and Francesco Monaco and Nereo Bresolin and Daniela Galimberti",
year = "2007",
month = "10",
day = "2",
doi = "10.1016/j.neulet.2007.08.020",
language = "English",
volume = "425",
pages = "173--176",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Candidate gene analysis of SPARCL1 gene in patients with multiple sclerosis

AU - Scalabrini, Diego

AU - Fenoglio, Chiara

AU - Scarpini, Elio

AU - De Riz, Milena

AU - Comi, Cristoforo

AU - Venturelli, Eliana

AU - Cortini, Francesca

AU - Piola, Mirko

AU - Villa, Chiara

AU - Naldi, Paola

AU - Monaco, Francesco

AU - Bresolin, Nereo

AU - Galimberti, Daniela

PY - 2007/10/2

Y1 - 2007/10/2

N2 - Recently, proteomic analysis in cerebrospinal fluid (CSF) from patients with MS identified four proteins which are present in MS but not in normal human CSF, including SPARCL1, an extracellular matrix-associated protein member of the SPARC family. One hundred eighty-six patients with MS and 185 age-matched controls were genotyped for A/G single nucleotide polymorphism (SNP) in exon 1 (rs1049539), C/G SNP in exon 4 (rs1049544), resulting in a substitution of an aspartate with an histidine, and A/G substitution in the exon 5 (rs1130643), leading to the substitution of alanine with threonine. No significant differences in either allelic or genotypic frequency of the three SNPs were found (P > 0.05), even in stratifying MS patients according to the course of the disease. Stratifying according to gender, a trend towards a decreased frequency of the C/C genotype of the rs1049544 was observed in male patients as compared with male controls (30.2% versus 44.0%; P = 0.217). Despite proteomic studies in CSF from MS patients suggested an important role for SPARCL1 in the development of the disease, SPARCL1 gene does not appear to act as susceptibility factor for MS in the population investigated here. However, the frequency of the C/C genotype of rs1049544 was decreased in male patients, possibly conferring a lower risk of developing MS in male population. Further studies are needed to clarify this issue.

AB - Recently, proteomic analysis in cerebrospinal fluid (CSF) from patients with MS identified four proteins which are present in MS but not in normal human CSF, including SPARCL1, an extracellular matrix-associated protein member of the SPARC family. One hundred eighty-six patients with MS and 185 age-matched controls were genotyped for A/G single nucleotide polymorphism (SNP) in exon 1 (rs1049539), C/G SNP in exon 4 (rs1049544), resulting in a substitution of an aspartate with an histidine, and A/G substitution in the exon 5 (rs1130643), leading to the substitution of alanine with threonine. No significant differences in either allelic or genotypic frequency of the three SNPs were found (P > 0.05), even in stratifying MS patients according to the course of the disease. Stratifying according to gender, a trend towards a decreased frequency of the C/C genotype of the rs1049544 was observed in male patients as compared with male controls (30.2% versus 44.0%; P = 0.217). Despite proteomic studies in CSF from MS patients suggested an important role for SPARCL1 in the development of the disease, SPARCL1 gene does not appear to act as susceptibility factor for MS in the population investigated here. However, the frequency of the C/C genotype of rs1049544 was decreased in male patients, possibly conferring a lower risk of developing MS in male population. Further studies are needed to clarify this issue.

KW - Haplotype

KW - Multiple sclerosis (MS)

KW - Single nucleotide polymorphism (SNP)

KW - SPARCL1

UR - http://www.scopus.com/inward/record.url?scp=34548671844&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548671844&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2007.08.020

DO - 10.1016/j.neulet.2007.08.020

M3 - Article

C2 - 17825989

AN - SCOPUS:34548671844

VL - 425

SP - 173

EP - 176

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 3

ER -